Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases. Under the terms of ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services, Inc. (“Relation”) announced today the promotions of Mark Kochner, Josh Bedgood, and Cary Taylor. “Mark, Josh, and Cary have ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Relation and healthcare investment firm Deerfield Management, a current investor, today announced the establishment of a new research collaboration to advance ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services, Inc. (“Relation”), one of the largest and fastest-growing national insurance agencies, announced today it acquired the assets of The ...
In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results